Related Experiment Video

Updated: Aug 18, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Myocardial reperfusion: its assessment and its relation to clinical outcomes

Raphaëlle Dumaine1, Brian Bigelow, Julian Aroesty

  • 1TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham & Women's Hospital, Boston MA 02115, USA.

The American Heart Hospital Journal
|April 9, 2005
PubMed

Insights

Restoring epicardial blood flow is not enough for acute coronary syndromes. Myocardial perfusion assessment, using simple angiographic markers like TIMI flow, is key for predicting clinical outcomes after heart attacks.

Area of Science:

  • Cardiology
  • Medical Diagnostics

Background:

  • Optimal clinical outcomes in acute coronary syndromes (ACS) require more than just restoring epicardial blood flow.
  • Clinical results are closely linked to myocardial perfusion, the actual blood supply to the heart muscle.

Purpose of the Study:

  • To review diagnostic tools for assessing myocardial perfusion after acute myocardial infarction (AMI).
  • To examine the association between these perfusion assessment tools and clinical outcomes.

Main Methods:

  • Review of diagnostic tools used to evaluate myocardial perfusion post-AMI.
  • Analysis of the correlation between various perfusion markers and patient outcomes.

Main Results:

  • Simple, readily available angiographic markers, including Thrombolysis in Myocardial Infarction (TIMI) count frame, TIMI myocardial perfusion grade, and pulsatile flow, show a strong relationship with clinical outcomes.
  • More complex diagnostic tools, while accurate, are limited by cost, availability, and complexity for routine clinical use.

Conclusions:

  • Simple angiographic measures of myocardial perfusion are valuable for predicting outcomes in acute myocardial infarction.
  • Accessible and straightforward diagnostic methods are preferred for routine clinical assessment of myocardial perfusion and patient prognosis.

More Related Videos

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice05:07

Dynamic Assessments of Coronary Flow Reserve after Myocardial Ischemia Reperfusion in Mice

Published on: August 25, 2023

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...